About Us
Products
- MARGENZA®
Pipeline
Technology
Patients
Investors
Careers
- Current Openings
- Employee Benefits

Site Map

Home Site Map

Warning: Undefined variable $add in /nas/content/live/macrogenics/wp-content/themes/macrogenics2023/functions.php on line 346

Homepage
About Us
Pipeline
Platforms
- DART^® and Trident™
- Fc Optimization
Patients
Investors
Careers
- Current Openings
- Employee Benefits
Contact Us
Privacy
Terms of Use

About Us
Our Living Values
Senior Management
Board of Directors
Collaborations
Corporate Compliance & Ethics
Contact Us

Products
MARGENZA®

Pipeline
MGC018 (B7-H3)
Lorigerlimab (PD-1 × CTLA-4)
Tebotelimab (PD-1 × LAG-3)
MGD024 (CD123 × CD3)
IMGC936 (ADAM9)
Enoblituzumab (anti-B7-H3)
Retifanlimab (PD-1)
MGD014 (HIV × CD3)

Technology
Platforms
Capabilities
Publications

Patients
Clinical Trials
Expanded Access
Resources

Investors
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Investor FAQs
Publications
Contact Investor Relations

Careers
Current Openings
Employee Benefits

©2023 MacroGenics, Inc.

Contact Us
Site Map
Privacy Policy
Terms of Use

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close